secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2023-02-22T23:59:59+00:00
Accession:  0000950170-23-003754
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia Biosciences shareholders approve reverse stock split at ratio up to 1:40
--------------------------------------------------------------------------------

- Reverse split ratio range of 1-for-10 to 1-for-40, board discretion, must occur before June 30, 2023.
- Proposal passed with 9,730,160,440 FOR vs 1,678,239,563 AGAINST; no broker non-votes.
- Adjournment proposal also approved with 9,995,797,812 FOR.
- Special meeting held Feb 15, 2023; record date Dec 30, 2022 with 24,642,960 common shares outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000095017023003754/0000950170-23-003754-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000095017023003754/rkda-20230215.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-003754

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer